![](https://investorshub.advfn.com/uicon/632715.png?cb=1505107773)
Monday, February 06, 2023 11:56:21 AM
April 7, 2021
WASHINGTON — The medical device industry gave doctors consulting fees, lunches, lodging, and other incentive payments worth $904 million between 2014 and 2017, per a new study — more than $80 million more than the pharmaceutical industry lavished on physicians over the same time period.
Experts told STAT that the findings, published Monday in Health Affairs, raise new questions about the industry’s influence on physician behavior — particularly since the medical device industry pulls in far less in revenue than the pharmaceutical industry.
Doctors must report any payments they receive from medical device makers, pharmaceutical companies, and other businesses in a government database called Open Payments that aims to help patients, researchers, and journalists understand the financial relationships that might be influencing a physician’s opinion. But until now, virtually all of the attention and scrutiny of the payments, as well as research into the links between the payments and physician behavior, has focused on pharma.
While a tight-knit relationship between medical device firms and physicians is often necessary for training and product development, the large scale of payments may inhibit the public’s trust between the patient and their provider, the researchers and other experts said.
If the relationship between the patient and physician is “contaminated by perverse financial incentives, then it does erode the public trust, which is a sacred value in our heritage, our great medical heritage,” said Marty Makary, professor of surgery and health policy at the Johns Hopkins School of Medicine, who was not involved in the research.
Medical device firm representatives often work side-by-side with physicians in the operating room, educating them on how to use their product and receiving feedback for developmental purposes. Helping a doctor learn how to use a pacemaker or insulin pump is very different from explaining the dosages of a new pill.
This intimate relationship has sparked the development of breakthrough medical products. But medical device representatives often use the increased face-time with physicians as an opportunity to pitch their products, according to the study and industry experts.
Both Alon Bergman, co-author of the study and postdoctoral researcher at the Leonard Davis Institute of Health Economics and the Wharton School, and Aaron Mitchell, an oncologist and health services researcher at Memorial Sloan Kettering Cancer Research Center, worried that the influence of a salesperson in the operating room creates blurred lines when doctors are deciding which product is best.
“I find that problematic,” said Mitchell, who was not involved in the research. “It becomes a lot harder to [decide which product is best] when that salesperson is also taking you out to $500 dinners and pays you tens of thousands of dollars in consulting fees over the last few years.”
https://coi.ufl.edu/2021/04/07/medical-device-firms-payments-to-doctors-far-outstripped-those-from-pharma-study-shows/
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM